Retractable Technologies (RVP) Common Equity (2010 - 2026)
Retractable Technologies' (RVP) quarterly Common Equity came in at $72.9 million in Q2 2026, down 4.71% on a YoY basis from $76.5 million in Q2 2025, and up 3.96% quarter-over-quarter from $70.1 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Common Equity (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Common Equity for 17 consecutive years, with $72.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity fell 4.71% year-over-year to $72.9 million; the trailing twelve-month figure through Jun 2026 stood at $72.9 million (down 4.71% YoY), and the FY2025 full-year result was $74.4 million, down 14.68% from the prior year.
- Common Equity advanced to $72.9 million in Q2 2026 per RVP's latest filing, from $70.1 million in the prior quarter.
- Across five years, Common Equity topped out at $109.0 million in Q3 2022 and bottomed at $70.1 million in Q1 2026.
- Historically, Common Equity has averaged $90.9 million across 5 years, with a median of $93.2 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Common Equity soared 55.25% in 2022, then declined 23.13% in 2025.
- Over 5 years, Common Equity stood at $106.5 million in 2022, then slipped by 6.8% to $99.3 million in 2023, then fell by 12.2% to $87.2 million in 2024, then dropped by 14.68% to $74.4 million in 2025, then dropped by 2.03% to $72.9 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $72.9 million, $70.1 million, and $74.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 24.42 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 19.08 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 2.99 Bn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 6.21 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 1.80 Bn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 121.30 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 35.09 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 72.87 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | -4.44 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 19.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.87 Mn |
| Mar 31, 2026 | 70.09 Mn |
| Dec 31, 2025 | 74.38 Mn |
| Sep 30, 2025 | 76.78 Mn |
| Jun 30, 2025 | 76.47 Mn |
| Mar 31, 2025 | 76.61 Mn |
| Dec 31, 2024 | 87.17 Mn |
| Sep 30, 2024 | 83.46 Mn |
| Jun 30, 2024 | 85.44 Mn |
| Mar 31, 2024 | 99.66 Mn |
| Dec 31, 2023 | 99.29 Mn |
| Sep 30, 2023 | 99.42 Mn |
| Jun 30, 2023 | 103.54 Mn |
| Mar 31, 2023 | 107.47 Mn |
| Dec 31, 2022 | 106.54 Mn |
| Sep 30, 2022 | 108.98 Mn |
| Jun 30, 2022 | 102.50 Mn |
| Mar 31, 2022 | 105.32 Mn |
| Dec 31, 2021 | 99.17 Mn |
| Sep 30, 2021 | 79.60 Mn |